Stramsen Biotech, founded in November 2020 and based in Houston, Texas, is a biopharmaceutical company dedicated to developing medicines using a natural plant-based approach. The company's core mission is to address both infectious and non-infectious diseases through innovative scientific methods. Stramsen Biotech aims to leverage the wonders of plant-based science to create effective and sustainable medical solutions, targeting a broad market that includes patients suffering from various ailments.
Notable figures affiliated with Stramsen Biotech include its CEO, board members, and investors who are committed to advancing the company's mission. Since its inception, Stramsen Biotech has made significant strides in the biopharmaceutical field, contributing to the development of novel treatments. The company's impact is reflected in its growing portfolio of plant-based medicines, which promise to offer safer and more natural alternatives to conventional pharmaceuticals.
